Oral Administration of a Novel, Synthetic Ketogenic Compound Elevates Blood β-Hydroxybutyrate Levels in Mice in Both Fasted and Fed Conditions
Nutrients · 2024
DOI: 10.3390/nu16203526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Maricel A Soliven und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Metabolic Medicine, Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tamp…. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, Fasting, Diet, Ketogenic, Ketosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of South Florida (USF) Foundation, USF Research Foundation Project, USF Department of Chemistry.
Abstract (Originalsprache)
Background/Objectives: Elevating ketone levels with therapeutic nutritional ketosis can help to metabolically manage disease processes associated with epilepsy, diabetes, obesity, cancer, and neurodegenerative disease. Nutritional ketosis can be achieved with various dieting strategies such as the classical ketogenic diet, the modified Atkins diet, caloric restriction, periodic fasting, or the consumption of exogenous ketogenic supplements such as medium-chain triglycerides (MCTs). However, these various strategies can be unpleasant and difficult to follow, so that achieving and sustaining nutritional ketosis can be a major challenge. Thus, investigators continue to explore the science and applications of exogenous ketone supplementation as a means to further augment the therapeutic efficacy of this metabolic therapy.
Methods
Here, we describe a structurally new synthetic triglyceride, glycerol tri-acetoacetate (Gly-3AcAc), that we prepared from glycerol and an acetoacetate precursor that produces hyperketonemia in the therapeutic range (2–3 mM) when administered to mice under both fasting and non-fasting conditions. Animal studies were undertaken to evaluate the potential effects of eliciting a ketogenic response systemically. Acute effects (24 h or less) were determined in male VM/Dk mice in both fasted and unfasted dietary states.
Results
Concentration levels of β-hydroxybutyrate in blood were elevated (βHB; 2–3 mM) under both conditions. Levels of glucose were reduced only in the fasted state. No detrimental side effects were observed.
Conclusions
Pending further study, this novel compound could potentially add to the repertoire of methods for inducing therapeutic nutritional ketosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Metabolic Medicine, Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
- Department of Chemistry, University of South Florida, Tampa, FL 33620, USA.
ORCID-Profile: Dominic P D'Agostino
Förderung
- University of South Florida (USF) Foundation
- USF Research Foundation Project
- USF Department of Chemistry
Zitieren
APA
Soliven, M. A., Rogers, C. Q., Williams, M. S., Thomas, N. N., Turos, E., & D'Agostino, D. P. (2024). Oral Administration of a Novel, Synthetic Ketogenic Compound Elevates Blood β-Hydroxybutyrate Levels in Mice in Both Fasted and Fed Conditions. Nutrients. https://doi.org/10.3390/nu16203526
Vancouver
Soliven MA, Rogers CQ, Williams MS, Thomas NN, Turos E, D'Agostino DP. Oral Administration of a Novel, Synthetic Ketogenic Compound Elevates Blood β-Hydroxybutyrate Levels in Mice in Both Fasted and Fed Conditions. Nutrients. 2024. doi:10.3390/nu16203526
BibTeX
@article{Soliven2024,
author = {Soliven, Maricel A and Rogers, Christopher Q and Williams, Michael S and Thomas, Natalya N and Turos, Edward and D'Agostino, Dominic P},
title = {Oral Administration of a Novel, Synthetic Ketogenic Compound Elevates Blood β-Hydroxybutyrate Levels in Mice in Both Fasted and Fed Conditions},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16203526}
}
EUVIMED